Early onset post transplantation lymphoproliferative disorders: Analysis of international data from 5 studies

Annals of Transplantation

Volumn 14, Issue 3, 2009, Pages 74-77

  Khedmat, Hossein ^a   Taheri, Saeed ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Dr Taheri Medical Research Group   (Iran)

Author keywords

Early onset; Lymphoma; Lymphoproliferative disorder; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BRAIN; BRAIN TUMOR; CANCER THERAPY; CLINICAL ARTICLE; DATA COLLECTION METHOD; GRAFT SURVIVAL; HUMAN; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MEDLINE; META ANALYSIS; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PROGNOSIS; QUESTIONNAIRE; REMISSION; SEARCH ENGINE; TIME; UNIVARIATE ANALYSIS; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; DATA ANALYSIS; GRAFT VERSUS HOST REACTION; REVIEW; STRUCTURED QUESTIONNAIRE; SURVIVAL RATE;

ADULT; BRAIN NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; PROGNOSIS; TIME FACTORS; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; QUESTIONNAIRES;

EID: 74949093136     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ho M, Jaffe R, Miller G et al.: The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation. 1988; 45(4): 719-27
2. Opelz G: Are post-transplant lymphomas inevitable? Nephrol Dial Transplant, 1996; 11(10): 1952-55
3. Opelz G, Dohler B: Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant, 2004: 4: 222
4. Opelz G, Henderson R: Incidence of non-Hodg-kin lymphoma in kidney and heart transplant recipients. Lancet, 1993: 342: 1514
5. Pourfarziani V, Taheri S, Lessan-Pezeshki M et al.: Lymphoma after living donor kidney transplantation: an Iranian multicenter experience. Int Urol Nephrol, 2008; 40(4): 1089-94
6. Avolio AW, Agnes S, Barbarino R et al.: Post-transplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series. Transplant Proc, 2007; 39(6): 1956-60
7. Koike J, Yamaguchi Y, Hoshikawa M et al.: Post-transplant lymphoproliferative disorders in kidney transplantation: histological and molecular genetic assessment. Clin Transplant, 2002; 16(Suppl.8): 12-17
8. Mamzer-Bruneel MF, Lome C, Morelon E et al.: Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoprolif-eration: A report of 16 cases observed in a single center. J Clin Oncol, 2000; 18(21): 3622-32
9. Jain M, Badwal S, Pandey R et al.: Post-transplant lymphoproliferative disorders after live donor renal transplantation. Clin Transplant, 2005; 19(5): 668-73
10. Kroes AC, van der Pijl JW, van Tol MJ et al.: Rapid occurrence of lymphoproliferative disease after pancreas-kidney transplantation performed during acute primary Epstein-Barr virus infection. Clin Infect Dis, 1997; 24(3): 339-13
11. Sheil AG: Patterns of malignancies following renal transplantation. Transplant Proc, 1999; 31: 1263-65
12. Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ: Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transpl Int, 2007; 20(3): 207-18
13. Caillard S, Pencreach E, Braun L etal: Simultaneous development of lymphoma in recipients of renal transplants from a single donor: donor origin confirmed by human leukocyte antigen staining and microsatellite analysis. Transplantation, 2005; 79(1): 79-84
14. Bakker NA, van Imhoff GW, Verschuuren EA et al.: Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant, 2005; 19(3): 327-34
15. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center. Transplantation, 1993; 56: 88-96
16. Walker RC, Paya CV, Marshall WF et al.: Pre transplantation seronegative Epstein-Barr virus status is the primary risk factor of posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant, 1995; 14: 214
17. Harmon WE, Dharnidharka VR: Lympho prolif-erative disease in children. Transplant Proc, 1999; 31:1268-69
18. Hanto DW: Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogen-esis and developing rational treatment strategies. Annu Rev Med, 1995; 46: 381-94
19. Leblond V, Sutton L, Dorent R et al.: Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol, 1995; 13(4): 961-68
20. Pourfarziani V, Einollahi B, Taheri S et al.: Associations of Human Leukocyte Antigen (HLA) haplotypes with risk of developing lymphoproliferative disorders after renal transplantation. Ann Transplant, 2007; 12(4): 16-22
21. rd ed. Baltimore: Williams & Wilkins, 1995; 1989